T2 Biosystems Debt to Equity Ratio 2013-2024 | TTOO
Current and historical debt to equity ratio values for T2 Biosystems (TTOO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. T2 Biosystems debt/equity for the three months ending September 30, 2024 was 0.00.
| T2 Biosystems Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $0.03B | $-0.01B | -2.54 |
| 2024-06-30 | $0.03B | $-0.01B | -4.68 |
| 2024-03-31 | $0.06B | $-0.04B | -1.66 |
| 2023-12-31 | $0.06B | $-0.03B | -2.24 |
| 2023-09-30 | $0.06B | $-0.02B | -3.25 |
| 2023-06-30 | $0.07B | $-0.04B | -2.02 |
| 2023-03-31 | $0.08B | $-0.05B | -1.66 |
| 2022-12-31 | $0.07B | $-0.04B | -1.87 |
| 2022-09-30 | $0.08B | $-0.03B | -2.40 |
| 2022-06-30 | $0.08B | $-0.04B | -2.06 |
| 2022-03-31 | $0.08B | $-0.03B | -2.91 |
| 2021-12-31 | $0.07B | $-0.01B | -5.69 |
| 2021-09-30 | $0.07B | $0.00B | -29.44 |
| 2021-06-30 | $0.07B | $0.01B | 7.76 |
| 2021-03-31 | $0.07B | $0.00B | -124.77 |
| 2020-12-31 | $0.07B | $0.01B | 8.06 |
| 2020-09-30 | $0.06B | $0.02B | 3.42 |
| 2020-06-30 | $0.06B | $0.00B | -13.24 |
| 2020-03-31 | $0.06B | $-0.01B | -7.67 |
| 2019-12-31 | $0.06B | $-0.03B | -1.84 |
| 2019-09-30 | $0.06B | $-0.03B | -2.32 |
| 2019-06-30 | $0.06B | $-0.02B | -3.89 |
| 2019-03-31 | $0.06B | $0.00B | -36.16 |
| 2018-12-31 | $0.05B | $0.01B | 4.65 |
| 2018-09-30 | $0.05B | $0.02B | 2.19 |
| 2018-06-30 | $0.05B | $0.03B | 1.63 |
| 2018-03-31 | $0.05B | $-0.01B | -5.18 |
| 2017-12-31 | $0.05B | $0.00B | 39.94 |
| 2017-09-30 | $0.05B | $0.02B | 2.84 |
| 2017-06-30 | $0.05B | $0.01B | 4.18 |
| 2017-03-31 | $0.05B | $0.03B | 1.91 |
| 2016-12-31 | $0.05B | $0.04B | 1.28 |
| 2016-09-30 | $0.04B | $0.05B | 0.82 |
| 2016-06-30 | $0.04B | $0.02B | 1.91 |
| 2016-03-31 | $0.04B | $0.04B | 1.14 |
| 2015-12-31 | $0.04B | $0.05B | 0.85 |
| 2015-09-30 | $0.03B | $0.02B | 1.23 |
| 2015-06-30 | $0.03B | $0.03B | 0.87 |
| 2015-03-31 | $0.03B | $0.04B | 0.67 |
| 2014-12-31 | $0.03B | $0.05B | 0.49 |
| 2014-09-30 | $0.02B | $0.06B | 0.28 |
| 2014-06-30 | $0.01B | $0.01B | 1.08 |
| 2014-03-31 | $0.01B | $0.02B | 0.56 |
| 2013-12-31 | $0.01B | $0.02B | 0.37 |
| 2013-09-30 | $0.00B | $0.00B | 0.00 |
| 2013-06-30 | $0.00B | $0.00B | 0.00 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.01B | $0.00B | 2.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.007B |
| T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.166B | 84.17 |
| Thermo Fisher Scientific (TMO) | United States | $153.961B | 18.62 |
| Alcon (ALC) | Switzerland | $47.401B | 31.51 |
| Edwards Lifesciences (EW) | United States | $44.018B | 28.86 |
| IDEXX Laboratories (IDXX) | United States | $39.134B | 44.97 |
| DexCom (DXCM) | United States | $32.682B | 50.51 |
| IQVIA Holdings (IQV) | United States | $26.521B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.538B | 26.80 |
| STERIS (STE) | Ireland | $22.108B | 25.28 |
| Waters (WAT) | United States | $20.558B | 29.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.317B | 0.00 |
| Hologic (HOLX) | United States | $12.352B | 13.42 |
| Sysmex ADR (SSMXY) | Japan | $11.507B | 0.00 |
| Penumbra (PEN) | United States | $11.201B | 87.92 |
| Globus Medical (GMED) | United States | $9.836B | 22.77 |
| Masimo (MASI) | United States | $8.139B | 30.02 |
| Teleflex (TFX) | United States | $5.395B | 8.90 |
| Glaukos (GKOS) | United States | $5.042B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| TransMedics (TMDX) | United States | $3.241B | 94.86 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| Veracyte (VCYT) | United States | $2.415B | 33.89 |
| LivaNova (LIVN) | United Kingdom | $2.372B | 14.12 |
| Nihon Kohden (NHNKY) | Japan | $2.127B | 11.63 |
| Elekta AB (EKTAY) | Sweden | $1.860B | 16.72 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.483B | 0.00 |
| Artivion (AORT) | United States | $1.212B | 113.52 |
| Pulse Biosciences (PLSE) | United States | $1.123B | 0.00 |
| OPKO Health (OPK) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.989B | 5.26 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.744B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.654B | 14.29 |
| IRadimed (IRMD) | United States | $0.649B | 32.91 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| RxSight (RXST) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| OrthoPediatrics (KIDS) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.469B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.453B | 0.00 |
| NeuroPace (NPCE) | United States | $0.397B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.317B | 6.73 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.58 |
| CVRx (CVRX) | United States | $0.195B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.55 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.29 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.14 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |